Physician profile
Stephen O'Connor
NPI 1548238512
$4,321.81
in general payments reported to CMS, 2019-2025
22 companies · $58.36 in 2025
The $58.36 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,760 · 2020: $590 · 2021: $501 · 2022: $743 · 2023: $167 · 2024: $502 · 2025: $58.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $728.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $727.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,027.03 | 2019-2024 | Avvigo Guidance System, Threader, Guidezilla |
| Astrazeneca Pharmaceuticals LP | $498.46 | 2019-2021 | |
| Saranas, INC. | $337.62 | 2022 | |
| Novartis Pharmaceuticals Corporation | $255.30 | 2019-2021 | |
| Shockwave Medical, INC | $250.43 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic Vascular, INC. | $154.41 | 2020 | |
| Abiomed | $146.13 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $129.96 | 2019-2024 | Lifevest |
| Pfizer INC. | $71.38 | 2019-2021 | |
| Philips North America LLC | $61.57 | 2019 | |
| Amgen INC. | $60.61 | 2020-2021 | |
| Medtronic, INC. | $52.55 | 2024-2025 | Complete Se Vascular, Affera Mapping System, Euphora |
| Kiniksa Pharmaceuticals International, Plc | $48.42 | 2024 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $47.48 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.38 | 2024-2025 | Jardiance |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $33.03 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $24.73 | 2019-2020 | |
| Abbott Laboratories | $22.99 | 2025 | Xience Skypoint |
| Regeneron Healthcare Solutions, INC. | $17.47 | 2019 | |
| Edwards Lifesciences Corporation | $16.60 | 2023 | |
| Astellas Pharma US INC | $14.72 | 2021 | |
| Amarin Pharma, INC. | $11.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen O'Connor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.